XOMA Limited (XOMA)
$0.73
0.00 (-0.27%)
| CAPS Rating |
|
|---|---|
| Open | $0.00 |
| Previous Close | $0.73 |
| Daily Range | $0.72 - $0.74 |
| 52-Week Range | $0.37 - $1.34 |
| Market Cap | $144.83M |
| P/E Ratio | 12.17 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 710,729 |
| Average Daily Volume | 2,048,000 |
This ticker is not currently Ratable.
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
XOMA Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
XOMA News and Commentary
- UPDATE 1-Xoma says intends to fully repay loan to Goldman Sachs – Reuters
- 5 More Stocks on Wall Street's Dollar Menu – The Motley Fool
- Navigating the Minefield of Micro-Cap Biotechs – Blog at The Motley Fool
- Making Cents in Penny Stocks – The Motley Fool
- Making Cents in Penny Stocks – The Motley Fool
- Closing XOMA (XOMA) underperform – Blog at The Motley Fool
- Thursday's Worst Stocks in the World – The Motley Fool
- 5 Stocks Approaching Greatness – The Motley Fool
- Tuesday's Biggest Stock Stars – The Motley Fool
- The Wall Street Buy List – The Motley Fool
- Get to Know a Guru – The Motley Fool
Related News and Articles
- Dream Stocks for Biotech Investors – The Motley Fool
- Still Enjoying Those Acquisitions, Pfizer? – The Motley Fool
- Novartis Didn't Know JAK, Until Now – The Motley Fool
- 4 Platform Drugmakers to Invest In – The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool
- A Big Upgrade for Allos Therapeutics – The Motley Fool
- Now's a Great Time to Invest -- So Don't Blow It Like This – The Motley Fool


RSS Headlines
Fool UK